Literature DB >> 2955734

Primary ciliary dyskinesia: quantitative investigation of the ciliary ultrastructure with statistical analysis.

S van der Baan, A J Veerman, P D Bezemer, L Feenstra.   

Abstract

In this study the ultrastructure of cilia in patients with primary ciliary dyskinesia was compared to that in patients with other respiratory infections and with that in healthy individuals. After statistical analysis of the findings, the prevalence and the specificity of morphological changes in primary ciliary dyskinesia were established. Guidelines were developed by which the existence of primary ciliary dyskinesia can be ascertained in biopsies of nasal mucosa via transmission electron microscopy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2955734     DOI: 10.1177/000348948709600306

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  4 in total

1.  Functional analysis of cilia and ciliated epithelial ultrastructure in healthy children and young adults.

Authors:  M A Chilvers; A Rutman; C O'Callaghan
Journal:  Thorax       Date:  2003-04       Impact factor: 9.139

2.  A case of sinobronchial syndrome progressing to diffuse panbronchiolitis despite low-dose, long-term macrolide therapy.

Authors:  Miki Abo; Yoshiaki Amino; Johsuke Hara; Noriyuki Ohkura; Takashi Sone; Hideharu Kimura; Kazuo Kasahara
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

3.  Distribution of retroviral p15E-related proteins in neoplastic and non-neoplastic human tissues, and their role in the regulation of the immune response.

Authors:  R A Scheeren; R A Oostendorp; S van der Baan; R M Keehnen; R J Scheper; C J Meijer
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

4.  Ciliary beat pattern is associated with specific ultrastructural defects in primary ciliary dyskinesia.

Authors:  Mark A Chilvers; Andrew Rutman; Christopher O'Callaghan
Journal:  J Allergy Clin Immunol       Date:  2003-09       Impact factor: 10.793

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.